Adherence of patients to perioperative glycemic management strategies and clinical outcomes for patients with and without diabetes
| Diabetes* | No diabetes† | Unknown diabetes status | |
| n (%) | 1165 (17.8) | 2049 (31.2) | 3362 (51.1) |
| Screening | |||
| Had an HbA1c in the past 12 months (n, %) | 697 (59.8) | 2049 (100.0) | 0 |
| Monitoring | |||
| Median number of POCT measurements per patient (IQR) | 4 (2–5) | 0 (0–0) | 0 (0–0) |
| Patients with no POCT measurements (%) | 197 (16.9) | 1841 (89.9) | 3115 (92.7) |
| Glycemic outcomes | |||
| No in-target POCT measurementsठ(%) | 192 (19.8) | 6 (2.9) | 20 (8.1) |
| All POCT measurements in targetठ(%) | 331 (34.2) | 166 (79.8) | 172 (70.4) |
| Any hyperglycemiaठ(%) | 636 (65.7) | 38 (18.3) | 69 (27.9) |
| Moderate hyperglycemiaठ(%) | 140 (16.9) | 1 (0.5) | 5 (2.1) |
| Severe hyperglycemiaठ(%) | 47 (5.1) | 0 | 3 (1.2) |
| An episode of hypoglycemiaठ(%) | 28 (2.9) | 6 (2.9) | 8 (2.9) |
| Recognition and treatment | |||
| Received insulin in hospital | 638 (55.8) | 24 (1.2) | 69 (2.1) |
| Any hyperglycemia | 458 (72.0) | 9 (23.7) | 31 (44.9) |
| Moderate hyperglycemia | 117 (83.6) | 1 (100.0) | 4 (80.0) |
| Severe hyperglycemia | 42 (89.4) | – | 3 (100.0) |
| Regimen | |||
| Sliding scale correction-only regimen | 409 (64.1) | 10 (76.9) | 50 (82.0) |
| Basal bolus insulin regimen | 229 (35.9) | 3 (23.1) | 11 (18.0) |
*DAD diagnosis or HbA1c ≥6.5%.
†No DAD diagnosis and HbA1c <6.5%.
‡Of patients with any POCT.
§Capillary glucose between 4.0 and 10.0 mmol/L is considered within target; moderate hyperglycemia is 14.0–17.9 mmol/L; severe hyperglycemia is ≥18.0 mmol/L.
DAD, discharge abstract database; HbA1c, hemoglobin A1c; POCT, point-of-care testing.